Organogenesis, Inc. partnered with BTIG and Citizens JMP Securities to issue up to $75M worth of Class A common stock through at-the-market sales, subject to shareholder approval and market availability restrictions.
Organogenesis, Inc. partnered with BTIG and Citizens JMP Securities to issue up to $75M worth of Class A common stock through at-the-market sales, subject to shareholder approval and market availability restrictions.